- Home
- GNLX vs RILYP Comparison
GNLX vs RILYP Comparison
Compare GNLX & RILYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- RILYP
- Stock Information
- Founded
- GNLX 2001
- RILYP 1973
- Country
- GNLX United States
- RILYP United States
- Employees
- GNLX N/A
- RILYP N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- RILYP Investment Managers
- Sector
- GNLX Health Care
- RILYP Finance
- Exchange
- GNLX Nasdaq
- RILYP Nasdaq
- Market Cap
- GNLX 109.4M
- RILYP N/A
- IPO Year
- GNLX 2023
- RILYP N/A
- Fundamental
- Price
- GNLX $3.38
- RILYP $4.67
- Analyst Decision
- GNLX Strong Buy
- RILYP
- Analyst Count
- GNLX 4
- RILYP 0
- Target Price
- GNLX $17.75
- RILYP N/A
- AVG Volume (30 Days)
- GNLX 152.0K
- RILYP 31.2K
- Earning Date
- GNLX 08-13-2025
- RILYP 01-01-0001
- Dividend Yield
- GNLX N/A
- RILYP 18.40%
- EPS Growth
- GNLX N/A
- RILYP N/A
- EPS
- GNLX N/A
- RILYP N/A
- Revenue
- GNLX N/A
- RILYP $854,383,000.00
- Revenue This Year
- GNLX N/A
- RILYP N/A
- Revenue Next Year
- GNLX N/A
- RILYP N/A
- P/E Ratio
- GNLX N/A
- RILYP N/A
- Revenue Growth
- GNLX N/A
- RILYP N/A
- 52 Week Low
- GNLX $1.60
- RILYP $1.73
- 52 Week High
- GNLX $5.89
- RILYP $20.00
- Technical
- Relative Strength Index (RSI)
- GNLX 63.14
- RILYP 79.22
- Support Level
- GNLX $2.80
- RILYP $2.02
- Resistance Level
- GNLX $3.61
- RILYP $4.78
- Average True Range (ATR)
- GNLX 0.21
- RILYP 0.41
- MACD
- GNLX 0.05
- RILYP 0.32
- Stochastic Oscillator
- GNLX 73.26
- RILYP 96.39
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About RILYP B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.